KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Total Debt (2016 - 2025)

Historic Total Debt for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $61.7 billion.

  • Pfizer's Total Debt fell 884.63% to $61.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 billion, marking a year-over-year decrease of 884.63%. This contributed to the annual value of $64.4 billion for FY2024, which is 1105.6% down from last year.
  • Latest data reveals that Pfizer reported Total Debt of $61.7 billion as of Q3 2025, which was down 884.63% from $61.8 billion recorded in Q2 2025.
  • Pfizer's Total Debt's 5-year high stood at $72.4 billion during Q4 2023, with a 5-year trough of $35.9 billion in Q2 2023.
  • Over the past 5 years, Pfizer's median Total Debt value was $61.7 billion (recorded in 2025), while the average stood at $52.6 billion.
  • In the last 5 years, Pfizer's Total Debt plummeted by 3831.14% in 2021 and then soared by 10127.97% in 2023.
  • Over the past 5 years, Pfizer's Total Debt (Quarter) stood at $38.4 billion in 2021, then dropped by 6.48% to $35.9 billion in 2022, then skyrocketed by 101.28% to $72.4 billion in 2023, then decreased by 11.06% to $64.4 billion in 2024, then fell by 4.1% to $61.7 billion in 2025.
  • Its Total Debt stands at $61.7 billion for Q3 2025, versus $61.8 billion for Q2 2025 and $62.1 billion for Q1 2025.